YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Design and Evaluation of Biphenyl Dimethyl Dicarboxylate Injections

비페닐디메칠디카르복실레이트 주사제의 설계 및 평가

  • Published : 2000.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

In an attempt to develop an injectable form of practically insoluble biphenyl dimethyl dicarboxylate (DDB), the effect of various vehicles, cosolvents and hydrotropic agents was investigated. It was found that polyethylene glycol (PEG) 400 revealed the best solvency toward DDB (17.7 mg/ml at $37^{\circ}C$), and decreasing order of the solubility was as follows: PEG 400>PEG 300>diethylene glycol monoethyl ether (DGME)>PEG-8 glyceryl caprylate/caprate. Among the hydrotropes used, sodium salicylate, sodium benzoate and nicotinamide were effective in increasing the solubility in water. The solubility of DDB in 2 M sodium salicylate, sodium benzoate and nicotinamide solutions was increased 44.3, 23.5 and 44.0 times than that in water, respectively. The addition of sodium salicylate and sodium benzoate to PEG 300-water PEG 400-water and DGME-water cosolvents remarkably increased the solubility of DDB, and significantly retarded precipitate formation when mixed with water Hemolytic properties of DDB injections (2 mg/4~10 ml) in PEG 300-water or DGME-water (60:40 v/v) cosolvents containing sodium benzoate (0.14~0.35 M) were very low. It was concluded from the results that these solutions would be applied to the design of new DDB injections.

Keywords

References

  1. Acta Pharm. Sinica v.16 Synthesis of scizandrin C analogs Xie. J.X.;Zhou. J. yang. J.H.;Chen. J.X.;Jin. H.Q.
  2. Acta Pham. Sinica v.18 From the study of Fructus schizandrae to the discovery of biphenyl dimethyl dicarboxylate Liu. K.T.
  3. Beijing Med. J. v.4 Therapeutic effects of DDB and traditional chinese medicine and alpha-feroprotein elevation of chronic viral hepatitis B and cirrhosis Chang. Y.X.;Yu. H.G.;Shi. J.Z.;Yong. A.L.
  4. Beijing Med J. v.6 Clinical effects of DDB pillues on 209cases of viral hepatitis and cirrhosis Wang. C.F.
  5. Kor. J. Clin. Pham. v.3 Clinical study for low dose and short-term therapy of bipheny! dimethyl dicarboxylate (DDB) in chronic hepatitis patients with elvetes serum aspartate aminotrasferase and alanine aminotransferase levels Kim D.W.;Kang. B.K.
  6. Chem. Biol. Interactions v.41 Pharmacological properties of dibenzo(a,c)cyclooctene derivatives isolated from Fructus Schizandrae. chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation metabolism and covalent binding of carbon tetrachloride to lipid Liu. K.T.;Lesca. P.
  7. Yakhak Hoeji v.43 Effect of biphenyl dimethyl dicarboxylate on cytochrome P450 1A1 and 2B1 and CCl₄-induced hepatotoxicity in rat liver. Kim. S.S.;Oh. H.Y.;Kim. H.R.;Yang. J.S.;Kim. D.S.;Sheen. Y.Y.;Choi. K.H.
  8. Acta Pharm. Sinica v.25 Biovailability studies on the preparations of biphenyl dimethyl dicarboxylate Gu. S.J.;Wang. X.L.;Gao. W.W.;Qiao. P.X.;Wang. A.G.;Qiang. Z.Y.;Song. Z.Y.
  9. Acta Pharm. Sinica v.24 The dissolution rate and physical dispersion state of preparations of biphenyl dimethyl dicarboxylate Gu. S.J.;Gao. W.W.;Qiao. P.X.;Wang. A.G.;Qiang. Z.Y.
  10. J. Kor. Pharm. Sci. v.24 Dissolution characteristics of biphenyl dimethyl dicarboxylate from solid dispersions and permeation through rabbit duodenal mucosa Hyun. J.;Chun. I.K.
  11. J. Kor. Pharm. Sci. v.26 Enhancement of dissolution properties through formulations of insoluble drug biphenyl dimethyl dicarboxylate Lee. S.A.;Song. K.;Park. E.J.;Sohn. D.H.;Go. G.I.;Kim. J.B.
  12. J. Kor. Pharm. Sci. v.28 Formulation optimization of the tablet prepared with solid dispersion of biphenyl dimethyl dicarboxylate with poloxamer Lee. J.W.;Park. E.S.;Chi. S.C.
  13. J. Kor. Pharm. Sci. v.29 Enhanced dissolution and permeation of biphenyl dimethyl dicarboxylate using solid dispersions Moon. J.H.;Chun. I.K.
  14. J. Kor. Pharm. Sci. v.26 Polymorphism of biphenyl dimethyl dicarboxylate Sohn. Y. T.;Park. M.S.;Kwon. S.K.
  15. J. Kor. Pharm. Sci. v.27 Effect of a water soluble dimethyl dimethoxy biphenylate derivative on the carbon tetrachloride induced hepatotoxicity in rats Moon. J.O.;Cheung. K.O.;Kim. S.H.;Kim. N.D.;Lee. S.K.;Yang. H.S.;Lee. C.H.
  16. 제 43회 대한약학회 총회 및 학술대회 요지집 v.PB39 혼합 미셀계를 이용한 DDB의 경구투여 제형 개발 김성남;심창구;이민화;김신근
  17. J. Kor. Pham. Sci. v.26 Solubilization and formulation as sorft gelatin capsule of biphenyl dimethyl dicarboxylate Park. G.B.;Chung. C.K.;Lee. K.P.
  18. J. Appl. Pharmacol. v.4 Design and pharmaceutical evaluation of biphenyl dimethyl dicarboxylate soft elastic capsules Chun. I.K.;Gwak. H.S.;Moon. J.H.
  19. J. Kor. Pharm. Sci. v.27 Solubilization of biphenyl dimethyl dicarboxylate in aqueous solution Bae. J.H.;Park. E.S.;Chi. S.C.
  20. The 27th Annual Academic Convenion of the Korean Society of Pharmaceutics Enhanced bioavailability of DDB Cho. Y.J.;Gao. Z.G.;Kim. C.K.
  21. Int. J. Pharm. v.34 Stabilization of hydrotropic temazepam perenteral formulations by lyophilisation Woolfson. A.D.;McCafferty. D.F.;Launchbury. A.P.
  22. Pharm. Res. v.13 Hydrotropic solubilization-mechanistic studies Coffman. R.E.;Kildsig. D.O.
  23. J. Pharm. Sci. v.78 Effects of hydrotropic agents on the solubility, precipitation and protein binding of etoposide Darwish. I.A.;Florence. A.T.;Saleh. A.M.
  24. J. Pharm. Sci. v.84 Preliminary safety evaluation of parenterally administered sulfoalkyl ether β-cyclodextrin derivatives Rajewski. R.A.;Traiger. G.;Bresnahan. J.;Jaberaboansari. P.;Stella. V.J.;Thompson. D.O.
  25. Int. J. Pharm. v.13 The solubility of benzodiazepines in sodium salicylate solution and a proposed mechanism of hydrotropic solubilization Badwan. A.A.;Ei-Khordagui. L.K.;Saleh. A.M.;Khalil. S.A.
  26. Drug Dev. Ind. Pharm. v.11 Enhanced solubility of paracetamol by various hydropic agents Hamza. Y.E.;Paruta. A.N.
  27. Pharmazie v.43 Hydrotropic solubilization of nifedipine Jain. N.K.;Patel. V.V.;Taneja. L.N.
  28. Biochem. Z. v.76 Hydrotropy Neuberg. C.
  29. Int. J. Pharm. v.24 Hydrotropic agents: a new definition Saleh. A.M.;EI-Khordagui. L.K.
  30. J. Pharm. Sci. v.68 Enhanced chartreusin solubility by hydroxybenzoate hydrotropy Poochikian. G.K.;Cradock. J.C.
  31. J. Pharm. Sci. v.80 Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs Muller. B.W.;Albers. E.